South Korean study links fine particulate air pollution to higher rheumatoid arthritis activity and flare risk

Exposure to fine particulate air pollution, particularly PM2.5 particles from sources such as dust, soot, and smoke, is associated with increased disease activity and a higher risk of flares in people with established rheumatoid arthritis (RA), according to a new prospective cohort study.

Researchers led by Eun Bong Lee of Seoul National University College of Medicine tracked 1,070 RA patients through 12,583 real-world outpatient visits over four years (2021–2024) at a major medical center in South Korea. They estimated individual exposure using monthly concentrations of six common air pollutants—sulfur dioxide (SO2), nitrogen dioxide (NO2), ozone (O3), carbon monoxide (CO), PM10, and PM2.5—and matched these with measures of disease activity and flare occurrence recorded at each visit, as detailed in the study published in the Annals of the Rheumatic Diseases (ard.eular.org).

Analyses adjusted for demographics, serologic status, medication use, socioeconomic factors, and meteorological variables. A sensitivity analysis using a case-crossover design with daily pollutant levels further controlled for time-invariant factors. Higher PM2.5 concentrations showed the strongest and most consistent associations with elevated disease activity scores, including tender and swollen joint counts, the Clinical Disease Activity Index (CDAI), and Disease Activity Score based on 28 joints (DAS28). Prolonged exposure to elevated PM2.5 over more than two weeks was notably linked to increased flare risk, Lee explained in materials released by Elsevier (elsevier.com).

According to reporting in MedPage Today, each 6 μg/m³ increment in PM2.5 was associated with an 11% increase in the odds of an RA flare (OR 1.113, 95% CI 1.017-1.218), while each 10 μg/m³ increment corresponded to a 0.052-point rise in DAS28 scores (medpagetoday.com). Air quality index values combining multiple pollutants also correlated with both flare risk and disease activity. Associations for other individual pollutants were weaker or inconsistent.

RA is a chronic autoimmune disease causing joint inflammation and damage that affects an estimated 0.5% to 1% of adults worldwide. Prior research has linked air pollution to higher risk of developing RA; this study examined effects on patients who already have the condition. PM2.5 particles, smaller than red blood cells, can enter the bloodstream after inhalation, potentially generating reactive oxygen species that cause cellular stress, DNA damage, and systemic inflammation capable of exacerbating RA, the investigators noted (sciencedaily.com).

In an accompanying editorial, Jeffrey A. Sparks of Mass General Brigham and Harvard Medical School described the work as one of the largest studies using robust methods to connect air pollutants with RA disease activity. He highlighted clinical, biologic, and public health implications, noting that avoiding poor air quality could help reduce flare risk and explain some otherwise unexplained flares (news-medical.net).

Lee stated that the findings have implications for public health policymaking and recommended that RA patients avoid prolonged exposure to poor air quality, especially high PM2.5 levels, while calling for further research on whether improving air quality reduces disease activity. Annals of the Rheumatic Diseases Editor-in-Chief Josef Smolen of the Medical University of Vienna cautioned that the results apply to the studied Korean population with its specific genetic and environmental context and that confirmation in other regions is needed. He called the environment an essential contributor to pain and inflammation in RA patients (healthcare-in-europe.com).

Coverage of the findings also appeared via PTI in The Hindu, which noted stronger associations in some subgroups such as women and nonsmokers (thehindu.com). Limitations include reliance on regional rather than personal exposure measurements and the single-country setting.